Watch More Highlights
Gloria Espinosa, PharmD, MAT, BCOP, of Thomas Jefferson University Hospital, discusses the delayed administration of pegaspargase for adults with acute lymphoblastic leukemia, which led to a lower rate of high-grade hepatotoxicity and subsequent treatment dose modifications while maintaining a similar response rate (Abstract 4239).